Chemical entities that modulate smooth muscle myosin and/or non-muscle myosin, pharmaceutical compositions and methods of treatment of diseases and conditions associated with smooth muscle myosin and/or non-muscle myosin are described.
描述了调节平滑肌肌凝蛋白和/或非肌肌凝蛋白的
化学实体、药物组合物以及治疗与平滑肌肌凝蛋白和/或非肌肌凝蛋白相关的疾病和病况的方法。